MSD, the developing company of simbastatin, will sell atorvastatin from the next month

MSD will launch the atorvastatin and ezetimibe hyperlipidemia complex ‘Atozet’ within the middle of the next month.

Atozet has been approved in 23 January 2015 and secured the base of the launch with the approval of the insurance benefit in 2 months after the approval.

Thus, followed by the launch of the simvastatin and ezetimibe complex ‘Vytorin’, MSD is about to launch 2 complexes along wit...